Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD).
Cytomegalovirus
antivirals
database
mutation
polymorphisms
resistance
Journal
Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
received:
27
05
2024
revised:
12
09
2024
accepted:
27
09
2024
medline:
1
10
2024
pubmed:
1
10
2024
entrez:
30
9
2024
Statut:
aheadofprint
Résumé
A comprehensive and accessible Herpesvirus drug resistance database was designed to serve as an international reference for diagnosis and clinical studies. This database available at https://www.unilim.fr/cnr-herpesvirus/outils/codexmv/ includes both resistance-related mutations and natural polymorphisms. Initially designed for human cytomegalovirus, it will be expanded to include herpes simplex and varicella-zoster viruses. Newly published mutations and new mutations reported by users or collaborating expert laboratories will be reviewed by an international committee of reference laboratories before inclusion in the database. Coupled with the Herpesvirus Sequence Analysis tool (HSA) mutation reports from NGS or Sanger sequences, it will be an open source for researchers in the field of Herpesviruses. We hope to fill this unmet need for the development and standardization of resistance genotyping.
Identifiants
pubmed: 39349222
pii: S0166-3542(24)00225-0
doi: 10.1016/j.antiviral.2024.106016
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106016Informations de copyright
Copyright © 2024. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest This comprehensive Antiviral Resistance database was developed by S. Alain, V. Tilloy, D. Díaz-González and S. Hantz at Limoges hospital as part of the ‘Centre National de Référence des Herpèsvirus’ tasks. The CHARMD database and the HSA tool, whose creators are among the authors of the article, are currently being registered with the French Agency for the Protection of Programs.